Results 121 to 130 of about 403,583 (300)

A drug cost model for injuries due to road traffic accidents.

Pharmacy Practice, 2008
Objective: This study aimed to develop a drug cost model for injuries due to road traffic accidents for patients receiving treatment at a regional hospital in Thailand. Methods: The study was designed as a retrospective, descriptive analysis.
Riewpaiboon A, Piyauthakit P, Srijariya W, Chaikledkaew U   +3 more
doaj  

Extensively Drug-Resistant Klebsiella pneumoniae Counteracts Fitness and Virulence Costs That Accompanied Ceftazidime-Avibactam Resistance Acquisition

, 2022
Elias Eger, Michael Schwabe, Lukas Schulig, Nils‐Olaf Hübner, Jürgen A. Bohnert, Uwe T. Bornscheuer, Stefan E. Heiden, Justus U. Müller, Fazal Adnan, Karsten Becker, Carlos L. Correa-Martínez, Sebastian Guenther, Evgeny A. Idelevich, Daniel Baecker, Katharina Schaufler   +14 more
openalex   +1 more source

Clinical Outcomes of Patients Within the Rheumatoid Arthritis Care Pathway Cohort at a Tertiary Care Integrated Delivery Network: A Comparison to Usual Care

Arthritis Care &Research, EarlyView.
Objective We aimed to compare clinical outcomes between patients in the Allegheny Health Network rheumatoid arthritis (RA) care pathway and patients receiving usual care. Methods The care pathway initiative implements guideline‐based best practice alongside multidisciplinary team‐based care.
Tarun Sharma, Tyson S. Barrett, Teigan Dwyer, Nancy Campbell, Jessica Heintzinger, Ellen Kraemer, Adam Dore, Susan Manzi   +7 more
wiley   +1 more source

Clinical practice and costs of treating catheter-related infections with teicoplanin or vancomycin

Pharmacy Practice, 2006
Objectives: To elicit actual clinical practice of treating intensive care unit patients with catheter-related infections with teicoplanin or vancomycin from a hospital perspective.
Simoens S, De Corte N, Laekeman G
doaj  

Drug Costs: What Can Infectious Diseases Physicians Do? [PDF]

J Infect Dis, 2020
Kapadia SN, Gulick RM.
europepmc   +1 more source

Drug Utilization, Dosing, and Costs After Implementation of Intravenous Acetaminophen Guidelines for Pediatric Patients

, 2014
Nicholas M. Fusco, Kristine A. Parbuoni, Jill Morgan   +2 more
openalex   +2 more sources

Temporal Trends in and Associations With Nonsteroidal Anti‐inflammatory Drug Prescription in Adult and Pediatric Patients With Inflammatory Bowel Disease

Arthritis Care &Research, EarlyView.
Objective Recent inflammatory bowel disease (IBD) treatment guidelines have recommended against nonsteroidal anti‐inflammatory drug (NSAID) use despite prevalent musculoskeletal symptoms and opioid overuse in this population. Given the discordance between changing national guidelines and potential clinical utility, we sought to assess national temporal
Adam S. Mayer, Rui Xiao, Andrew Grossman, Meenakshi Bewtra, Michael D. George, Pamela F. Weiss   +5 more
wiley   +1 more source

Distribution and predictors of haemophilia-related costs in the United Kingdom: analysis of the CHESS I and CHESS II burden of illness studies

BMC Health Services Research
Background Few studies have evaluated direct medical or societal costs of haemophilia in the United Kingdom (UK), and how patient characteristics impact future costs is uncertain.
Ione Woollacott, Amit Chhabra, Tom Burke, Jack Brownrigg, Lucy Richardson, Enrico Ferri Grazzi, Jamie O’Hara, Josie Godfrey, Michael Laffan   +8 more
doaj   +1 more source

Review of Current Policy Strategies to Reduce US Cancer Drug Costs. [PDF]

J Clin Oncol, 2020
Green AK, Ohn JA, Bach PB.
europepmc   +1 more source

Good Research Practices for Measuring Drug Costs in Cost-Effectiveness Analyses: Medicare, Medicaid and Other US Government Payers Perspectives: The ISPOR Drug Cost Task Force Report—Part IV

, 2009
C. Daniel Mullins, Brian Seal, Enrique Seoane‐Vazquez, Jayashri Sankaranarayanan, Carl V. Asche, Ravishankar Jayadevappa, Won Chan Lee, Dorothy Romanus, Junling Wang, Joel W. Hay, Jim Smeeding   +10 more
openalex   +1 more source